Meeting Details
Meeting Date: Monday, November 2, 2026
Agenda Items
The Board of Directors will consider and approve:
- Un-audited Standalone Financial Results for the quarter and half year ended September 30, 2026
- Un-audited Consolidated Financial Results for the quarter and half year ended September 30, 2026
- Limited review reports for both standalone and consolidated results for the same period
Financial Impact
Financial results for Q2 FY27 (quarter ended September 30, 2026) are pending board approval. Actual financial figures and impact will be disclosed post-board meeting approval.